Page 12 - Abt News Today

O Brien Greene & Co. Inc cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,689 shares of the healthcare product maker’s stock after selling 125 shares during the period. […]

Argonautica Private Wealth Management Inc. lowered its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,622 shares of the healthcare product maker’s stock after selling 237 shares during the quarter. Abbott Laboratories accounts […]

Golden State Equity Partners lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,373 shares of the healthcare product maker’s stock after purchasing an additional 543 […]

South Dakota Investment Council reduced its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 22.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,338 shares of the healthcare product maker’s stock after selling 2,100 shares during the period. […]

Bank of New Hampshire lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 8.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 11,462 shares of the healthcare product maker’s stock after selling 1,020 shares during the quarter. Bank of New […]

Meritage Portfolio Management increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 30.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,916 shares of the healthcare product maker’s stock after purchasing an additional 910 shares during the quarter. Meritage Portfolio […]

Meritage Portfolio Management boosted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 30.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,916 shares of the healthcare product maker’s stock after purchasing an additional 910 shares during […]

Ghe LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,547 shares of the healthcare product maker’s stock after acquiring an additional 182 shares during […]

Lyell Wealth Management LP lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,358 shares of the healthcare product maker’s stock after selling 4,635 shares during the quarter. Lyell Wealth Management […]

Larson Financial Group LLC trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 21.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,640 shares of the healthcare product maker’s stock after selling 449 shares during the period. Larson Financial Group […]